mepindolol has been researched along with Angor Pectoris in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonelli, J; Gazo, F; Kirsch, P; Liedtke, RK | 1 |
| Bonelli, J; Falkner, C; Gazo, F; Liedtke, RK | 1 |
| Bonelli, J; Gazo, F; Liedtke, RK | 1 |
3 trial(s) available for mepindolol and Angor Pectoris
| Article | Year |
|---|---|
Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiography; Female; Heart Rate; Humans; Male; Nitroglycerin; Pindolol; Skin Absorption | 1991 |
[Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate].
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Electrocardiography; Humans; Male; Middle Aged; Nitroglycerin; Pindolol | 1990 |
[Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Pindolol | 1989 |